Human VEGF R2/KDR ELISA Kit检测试剂盒(酶联免疫吸附法)
¥1,600.00 – ¥2,650.00
在售SKU:70-EK1159-48, 70-EK1159-96, EK1159
- 分子靶点:KDR
- 种属:人
- 样本类型:血清、血浆、细胞培养上清及其他生物学样本
- 检测样本体积:血清、血浆样本10μL
- 灵敏度:0.52pg/mL
- 检测范围:62.5-4000pg/mL
- 回收率:88%-107%
ELISA试剂盒详细信息
商品名 | 人血管内皮生长因子受体2/激酶插入区受体酶联免疫检测试剂盒 |
---|---|
种属 | 人 |
靶点 | KDR |
检测方法 | 双抗体夹心法 |
检测样本类型 | 血清、血浆、细胞培养上清及其他生物学样本 |
检测样本体积 | 血清、血浆样本10μL |
灵敏度 | 0.52pg/mL |
线性范围 | 62.5-4000pg/mL |
精密度 | 板内变异系数:3.7%-4%;板间变异系数:3.6%-3.9% |
回收率 | 88%-107% |
平均回收率 | 94% |
板式 | 96孔板,可拆 |
保存条件 | 2-8℃保存。已拆开:标准品-20℃保存,其它4℃。 |
运输条件 | 2-8℃冰袋运输 |
检测原理 | 本试剂盒采用双抗体夹心酶联免疫吸附检测技术。特异性抗人VEGFR2抗体预包被在高亲和力的酶标板上。酶标板孔中加入标准品、待测样本和生物素化的检测抗体,经过孵育,样本中存在的VEGFR2与固相抗体和检测抗体结合。洗涤去除未结合的物质后,加入辣根过氧化物酶标记的链霉亲和素(Streptavidin-HRP)。洗涤后,加入显色底物TMB,避光显色。颜色反应的深浅与样本中VEGFR2的浓度成正比。加入终止液终止反应,在450nm波长(参考波长570 - 630nm)测定吸光度值。 |
分子信息
KDR 分子靶点信息概述
- 分子名:KDR, kinase insert domain receptor
- 基因家族:Receptor tyrosine kinases; CD molecules; V-set domain containing; I-set domain containing
- 别名:FLK1; VEGFR; VEGFR2; CD309
- 全称:vascular endothelial growth factor receptor 2; fetal liver kinase 1; kinase insert domain receptor (a type III receptor tyrosine kinase)
KDR 分子靶点综述
血管内皮生长因子受体2(VEGFR2)也称为激酶插入区受体(KDR),是酪氨酸激酶受体(RTKs)III类亚家族成员。与VEGFR1相比,VEGFR2更广泛分布表达于说要血管衍生的内皮细胞。VEGFR2与VEGF-A(VEGF121、VEGF165、VEGF189和VEGF206剪切变体)、VEGF-C和VEGF-D结合。可溶性VEGFR1和VEGFR2在阻断VEGF诱导的细胞增殖和迁移方面差异非常显著。可溶性VEGFR2与可溶性VEGFR1相反,它无法与VEGF竞争,与表达VEGFR1和VEGFR2的内皮细胞结合。可溶性VEGFR2只能部分抑制细胞迁移,而可溶性VEGFR1几乎完全阻断VEGF诱导的细胞增殖和迁移。VEGF与可溶性VEGFR2而非VEGFR1的结合也依赖于肝素。VEGF/VEGFR2信号通路在肿瘤发生和其它病理性血管发生的疾病中具有重要作用。利用阻断抗体使功能性VEGFR2功能失活可破坏血管生成,阻止肿瘤细胞扩散。
人 Human KDR 分子靶点信息
- 分子名:KDR, kinase insert domain receptor
- 别称:
- CD309
- fetal liver kinase 1
- fetal liver kinase-1
- FLK1
- kinase insert domain receptor (a type III receptor tyrosine kinase)
- protein-tyrosine kinase receptor Flk-1
- soluble VEGFR2
- tyrosine kinase growth factor receptor
- vascular endothelial growth factor receptor 2
- VEGFR
- VEGFR2
- 基因序列:NCBI_Gene: 3791
- 蛋白序列:UniProtKB: P35968
人 Human KDR靶点分子功能(预测)
Enables several functions, including cell adhesion molecule binding activity; vascular endothelial growth factor binding activity; and vascular endothelial growth factor-activated receptor activity. Involved in several processes, including intracellular signal transduction; positive regulation of endothelial cell migration; and protein phosphorylation. Acts upstream of or within several processes, including branching involved in blood vessel morphogenesis; positive regulation of mitochondrial depolarization; and positive regulation of mitochondrial fission. Located in several cellular components, including Golgi apparatus; endosome; and membrane raft. Is integral component of plasma membrane. Implicated in several diseases, including artery disease (multiple); gastrointestinal system cancer (multiple); glioblastoma; macular degeneration (multiple); and pancreatic cancer (multiple). Biomarker of several diseases, including breast cancer (multiple); carcinoma (multiple); cerebrovascular disease (multiple); eye disease (multiple); and systemic scleroderma (multiple).